News

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 34.8% in the afternoon session after the company reported disappointing first-quarter 2025 earnings as sales fell below Wall Street's expectations. Another blemish was that while full-year revenue guidance was raised, full-year EBITDA guidance was maintained, signaling that profit margins for the year would be lower than initially expected. On the other hand, NeoGenomics beat analysts' EPS expectations, and its full-ye

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 34.8% in the afternoon session after the company reported disappointing first-quarter 2025 earnings as sales fell below Wall Street's expectations. Another blemish was that while full-year revenue guidance was raised, full-year EBITDA guidance was maintained, signaling that profit margins for the year would be lower than initially expected. On the other hand, NeoGenomics beat analysts' EPS expectations, and its full-ye

(Reuters) -U.S. corporate bond markets are showing signs of caution about the economy and inflation despite a rebound in new issuances and credit spreads in the weeks since President Donald Trump first announced harsh tariffs and then provided temporary relief on them, bond market experts said. Some 15 investment-grade companies, including Google's parent Alphabet, issued new bonds on Monday. In a sign that the administration’s rollbacks on some tariffs had brought back investor appetite, the issuances that raised a total of $18.3 billion saw $95 billion in orders, according to Informa Global Markets data.

Shares of metal packaging products manufacturer Crown Holdings (NYSE:CCK) jumped 8.3% in the afternoon session after the company reported a nice "beat and raise" quarter. Crown Holdings blew past analysts' EPS expectations on a smaller revenue beat. Sales rose modestly by 4%, lifted by increased shipments in beverage cans. Looking ahead, the company raised its full-year EPS guidance, which was encouraging. Zooming out, we think this was a good quarter with some key areas of upside.

Shares of environmental solutions provider CECO Environmental (NASDAQ:CECO) jumped 18.3% in the afternoon session after the company reported strong first quarter 2025 results: its revenue surged past Wall Street's expectations, and adjusted EPS outpaced forecasts. The real story this quarter was a 40% jump in sales, fueled by record-breaking orders and a backlog that climbed 55%. Full-year guidance remained intact, with CECO expecting roughly 30% revenue growth and a 50% jump in adjusted EBITDA,

Shares of hospital operator Tenet Healthcare (NYSE:THC) jumped 12.2% in the afternoon session after the company reported first-quarter 2025 results, which blew past analysts' EPS expectations on a solid revenue beat. Even though total revenue dipped a bit, that was mostly from selling off some hospitals. Looking ahead, Tenet raised its full-year adjusted EPS guidance, while keeping its revenue outlook unchanged, signaling confidence in margin expansion even without top-line acceleration. Overall

Shares of biotech company Regeneron (NASDAQ:REGN) fell 9.6% in the morning session after the company reported weak first-quarter 2025 results. Its revenue missed significantly, and its EPS fell short of Wall Street's estimates. Revenue declined 4% from the prior year, as Regeneron struggled to offset the double-digit decline in net product sales, including a 29% plunge in legacy EYLEA, despite a 54% jump in EYLEA HD. Overall, this quarter could have been better.